Pictet Alternative Advisors (PAA) has launched a private equity strategy focused on health investments.
The fund invests in best-in-class biotech and healthcare-focused venture capital, growth and private equity funds globally.
A significant allocation is dedicated to co-investments, a minority investment made directly into a company alongside another private equity investor during a transaction.
The strategy takes advantage of the move to health-driven practices across society and targets five key segments including therapeutics, diagnostics, digital health, medical technology and health care, and service providers, to create a diversified portfolio of private health care companies.
“Health is a major priority for society as a whole. We are at an inflection point for medical breakthroughs: investment is growing, regulation is becoming more supportive, and technology is able to offer more potential solutions,” said Yann Mauron, investment manager of the strategy. “As illustrated by the recent vaccine successes, it’s a fertile time for healthcare. What could have taken scientists 10 years to complete was accomplished in less than one.”
Pierre Stadler, head of thematic private equity at the firm, added: “From a private equity standpoint, the five areas provide opportunities across the full spectrum of company maturities. Deal flow in therapeutics, digital health and diagnostics is particularly strong in early and growth stages. Medtech and care providers, meanwhile, tend to be more attractive at buyout stage.”
© 2022 funds europe
